Skip to main content

Part of the book series: Keynes Seminars ((KESE))

Abstract

The old idea of the blood purification of a diseased body has acquired a new sense and real possibilities over the last two decades. There are at least two sources for this phenomenon: deeper insights into pathological processes of diseases based on rapid progress in biochemistry, immunology and the genetic sciences, and the development of numerous separation techniques also suitable for blood constituents, particularly for plasma components. A straightforward line can be seen from separation techniques such as plasmapheresis/plasma exchange over cryofiltration, cascade filtration methods and the use of broad-based adsorbents such as charcoal up to the development of selective and specific adsorbents for the binding of only a few components or even one certain plasma constituent. The selective and/or specific removal of pathologically relevant components without any influence on other plasma substances is the aim of a modern plasma treatment therapy. For these purposes, various adsorbents have been developed. Table 1 gives examples of specific immunoadsorbents acting on the principle of the antigen-antibody reaction. (For the research groups see references.) Work in Rostock has involved investigations relating to the development of selective adsorbents. This publication describes aspects of this research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Behm, E., Kuroda, T., Yamawaki, N., Tsuda, N., Loth, F., Schwachula, G., Sabrowski, E., Falkenhagen, D. and Klinkmann, H. (1987a). In vitro investigations with selective adsorbents for IgE and IgM. Biomaterials, Artificial Cells, and Artificial Organs, 15(1), 101–111.

    Google Scholar 

  • Behm, E., Toewe, D., Kuroda, T., Yamawaki, N., Tsuda, S., Ernst, B. and Klinkmann, H. (1987b). Binding of lipids by a newly developed synthetic material. 1st Int. Congr. Wld Apheresis Ass., Tokyo, Japan, in press.

    Google Scholar 

  • Bensinger, W. I., Baker, D. A., Buckner, C. D., Clift, R. A. and Thomas, E. D. (1981). Immunoadsorption for removal of A and B blood-group antibodies. New Engl J. Med., 304, 160–162.

    Article  Google Scholar 

  • Björk, L. and Kronvall, G. (1984). Purification and some properties of streptococcal protein G, a novel IgG binding reagent. J. Immun., 133, 969–974.

    Google Scholar 

  • Borberg, H., Bode, C., Mattele, L., Oette, K., Taucher, M. and Stoffel, W. (1983). LDL-apheresis in hypercholesterolemic patients: technical and clinical aspects, in M. J. Lysaght and H. J. Gurland (eds), Plasma Separation and Plasma Fractionation, Karger, Basel, pp. 266–271.

    Google Scholar 

  • Forsgren, A., Ghetie, V., Lindmark, R. and Sjöquist, J. (1983). Protein A and its exploitation, in C. S. F. Easmon and C. Adlam (eds), Staphylococci and Staphylococcal Infections 2, Academic Press, London, pp. 429–480.

    Google Scholar 

  • Kuroda, T., Okamoto, T., Yokoyama, T., Yamawaki, N., Inagaki, K., Umegae, M., Yokoyama, S. and Yamamoto, A. (1987). High capacity adsorbent of low density lipoprotein (LDL) for plasmapheresis. 1st Int. Congr. Wld Apheresis Ass., Tokyo, Japan, in press.

    Google Scholar 

  • Langone, J. J. (1982). Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumococci. Adv. Immun., 32, 157–252.

    Article  Google Scholar 

  • Nilsson, I. M., Sundquist, S.-B., Ljung, R., Holmberg, L., Freiburghaus, C. and Björlin, G. (1983). Suppression of secondary antibody response by intravenous immunoglobulin in a patient with haemophilia B and antibodies. Scand. J. Haematol., 30, 458–464.

    Article  Google Scholar 

  • Odaka, M., Kobayashi, H., Tabata, Y., Soeda, K., Hayashi, H., Ito, S., Murotani, N., Saito, Y., Nishide, Y., Shinomiya, M. and Yoshida, S. (1987). Long term results of LDL selective plasma adsorption therapy of familial hypercholesterolemia. Biomaterials, Artificial Cells and Artificial Organs, 15(1), 113–124.

    Google Scholar 

  • Reis, K. J., Ayoub, E. M. and Boyle, M. D. P. (1984a). Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. J. Immun., 132, 3091–3096.

    Google Scholar 

  • Reis, K. J., Ayoub, E. M. and Boyle, M. D. P. (1984b). Streptococcal Fc receptors. II. Comparison of the reactivity of a receptor from a group C streptococcus with staphylococcal protein A. J. Immun., 132, 3098–3102.

    Google Scholar 

  • Sato, T., Nishimiya, J., Arai, K., Anno, M., Yamawaki, N., Kuroda, T. and Inagaki, K. (1983). Selective removal of anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis in vitro with a new immunoadsorbent, in T. Oda (ed.), Therapeutic Plasmapheresis III, Schattauer Verlag, Stuttgart, pp. 565–568.

    Google Scholar 

  • Stoffel, W. and Bode, C. (1984). Selective removal of low density lipoproteins, in A. A. Pineda (ed.), Selective Plasma Component Removal, Futura Publ. Co., Mount Kisco, New York, pp. 1–22.

    Google Scholar 

  • Terman, D. S., Buffaloe, G., Mattioli, C., Cook, G., Tilquist, R., Sullivan, M. and Ayus, J. C. (1979). Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus. Lancet, II, 824–827.

    Google Scholar 

  • Traeger, J., Laville, M., El Habib, R., Moskovtchenko, J. F., Coulet, P. R. and Gautheron, D. C. (1983). Extracorporeal immunoadsorption of DNA-antibodies on DNA-coated collagen films: first results in systemic lupus erythematosus, in Y. Nosé, P. S. Malchesky and J. W. Smith (eds), Plasmapheresis: New Trends in Therapeutic Applications, ISAO Press, Cleveland, OH, pp, 155–166.

    Google Scholar 

  • Tsuruta, Y., Maeda, K., Shinzato, T., Sezaki, R., Usuda, M., Yamada, K., Obayashi, S., Saito, A., Ohta, K., Yamawaki, N., Kuroda, T. and Inagaki, K. (1983). Clinical application of improved 1–02 immunosorbent column, in Y. Nosé, P. S. Malchesky and J. W. Smith (eds), Plasmapheresis: New Trends in Therapeutic Applications, ISAO Press, Cleveland, OH, pp. 149–154.

    Google Scholar 

  • Yamazaki, Z., Fujimori, Y., Iizoka, I., Kanai, F., Takahama, T., Wada, T., Asano, K., Yoshizawa, H., Takahashi, Y., Ogita, T., Inoue, N., Yamawaki, N., Inagaki, K. and Tsuda, N. (1984). Immunosorbent plasma perfusion in patients with rheumatoid arthritis or systemic lupus erythematosus. Progr. artif. Organs, No. 204, Vol. 2, 708–712.

    Google Scholar 

  • Yokoyama, S., Hayashi, R., Kikkawa, T., Tani, N., Takada, S., Hatanaka, K. and Yamamoto, A. (1984). Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis. Arteriosclerosis, 4, 276–282.

    Article  Google Scholar 

  • Yokoyama, S., Hayashi, R., Satani, M. and Yamamoto, A. (1985). Selective removal of low density lipoproteins by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis, 5, 613–622.

    Article  Google Scholar 

Download references

Authors

Editor information

J. P. Paul A. B. McCruden P. W. Schuetz

Copyright information

© 1988 Bioengineering Unit, University of Strathclyde

About this chapter

Cite this chapter

Behm, E., Falkenhagen, D., Klinkmann, H., Courtney, J.M. (1988). Novel Approaches to Blood Purification. In: Paul, J.P., McCruden, A.B., Schuetz, P.W. (eds) The Influence of New Technology on Medical Practice. Keynes Seminars. Palgrave, London. https://doi.org/10.1007/978-1-349-09609-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-349-09609-1_13

  • Publisher Name: Palgrave, London

  • Print ISBN: 978-1-349-09611-4

  • Online ISBN: 978-1-349-09609-1

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics